Daxing Biomedical Industry Base in Zhongguancun Science Park, also known as "China Pharmaceutical Valley", was established in 2002. After more than 20 years of development, its output value has exceeded 100 billion yuan. The planned area of the park is 22.5 square kilometers, including 13.4 square kilometers of the existing area and 9.1 square kilometers of the expanded area. The park is the largest professional park in the field of medicine and health in the country and the only professional park in Zhongguancun named after medicine and health. With the goals of "building China Pharmaceutical Valley with international influence, forming an industrial innovation ecosystem of 'Medicine · Technology + Finance · Service', and creating a world-class professional park operator", taking leading enterprises in the industrial chain and characteristic industrial parks as the starting points, it has been continuously making efforts in track layout, product cultivation, enterprise introduction, talent service, and event holding. There are currently 300,000 square meters of available standard factory buildings in the park, and 120,000 square meters will be available within three years, providing sufficient development space for projects at different stages.

Industries

The park has formed four leading sectors, namely biopharmaceuticals, innovative chemical drugs, modern traditional Chinese medicine, and high-end medical devices, as well as two expanding sectors of digital healthcare and big health. The park has obvious advantages in the field of vaccines, with well-known listed enterprises such as Sinovac Biotech (Beijing) Co., Ltd., Minhai Biotechnology Co., Ltd., and Walvax Biotechnology Co., Ltd. having settled here. It has also attracted a number of leading enterprises at home and abroad, such as Fresenius Kabi, a Fortune 500 company from Germany, and Beijing Tongrentang, a time-honored brand in China. Moreover, it has cultivated a batch of high-growth enterprises such as Yiling Pharmaceutical Co., Ltd., Hotgen Biotech Co., Ltd., and Yimiao Medical Co., Ltd. A number of innovative achievements with international influence have emerged, such as CAR-T, total alkaloids of mulberry branches tablets, and artificial musk.

Advantages for development

Gathering of Authoritative Institutes: Twelve national-level inspection and R & D institutions, including the National Institutes for Food and Drug Control, the China Institute of Veterinary Drug Control, and the Institute of Materia Medica of the Chinese Academy of Medical Sciences, have settled in the park, endowing the industrial development of the park with power. The park has jointly built a quality inspection platform for biological products (vaccines, cell and gene therapy drugs, etc.) with the National Institutes for Food and Drug Control, and a transformation platform for innovative drug achievements with the Institute of Materia Medica, accelerating the transfer, transformation and industrialization of innovative achievements.

Introduction of Resources from Capital Medical University: Capital Medical University has relocated its main campus and graduate school to the park as a whole, and newly built an innovation center and a research-oriented hospital. The university supplies high-level professional talents in fields such as medicine, pharmacy, and medical devices to the park. The innovation center outputs a large number of innovative achievements to the park. The research-oriented hospital adheres to the combination of clinical practice and scientific research, continuously gives birth to high-level talents and high-quality achievements in independent innovation, and forms a benign interaction with the innovative development of the park.

Perfect Service System: Create a multi-level and wide-ranging common technology service system and construct a integrated development model of "Medicine · Technology + Finance · Service". Improve the full-industry-chain services of "new drug screening - animal experiments - clinical research - registration and listing - market sales", and accelerate the construction of core platforms such as the Beijing Bioinformatics Intelligent Computing Center and the Joint Laboratory for Quality Control Technology Testing of Biopharmaceuticals. Focus on characteristic tracks, provide specific services, gather outstanding talents, and formulate special policies to accelerate the construction of six characteristic industrial parks such as the Beijing International Nucleic Acid Drug Industrial Park. Set up various industrial funds to build a multi-level financial service system.

Supporting facilities

The comprehensive supporting service facilities such as education, medical care, conference and exhibition, culture and sports, and art venues are well-equipped.